ALKERMES | ALKS - Market Capitalization


ALKERMES reported $7.82B in Market Capitalization this August of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
AbbVie USD 435.86B 8.73B Aug/2026
Acadia Pharmaceuticals USD 4.53B 199M Aug/2026
ALKERMES USD 7.93B 806M Aug/2026
Amgen USD 209.65B 14.21B Aug/2026
Biogen USD 31.9B 5B Jun/2026
BioMarin Pharmaceutical USD 11.71B 651M Aug/2026
Bristol-Myers Squibb USD 117.66B 6.17B Jun/2026
Coherus Biosciences USD 172M 19M Dec/2025
Eli Lilly USD 1.11T 18.32B Aug/2026
Gilead Sciences USD 168.68B 11.82B Aug/2026
Heron Therapeutics USD 238M 7M Dec/2025
Ionis Pharmaceuticals USD 13.1B 642M Jun/2026
J&J USD 611.36B 32.21B Jun/2026
Malin Corporation EUR 133.52M 29.05M Aug/2026
Merck USD 324.18B 6.81B Aug/2026
Nektar Therapeutics USD 12.98B 10.86B Aug/2026
Neurocrine Biosciences USD 16.95B 3.7B Jun/2026
Otsuka Holdings JPY 5.87T 111.31B Jun/2026
Ovoca Bio EUR 5.1M 3.93M Aug/2026
Pfizer USD 153.17B 14.73B Aug/2026
Regeneron Pharmaceuticals USD 65.37B 16.31B Jun/2026
Vertex Pharmaceuticals USD 137.33B 11.26B Aug/2026